Leukemia, Myelodysplasia, Transplantation
From the Journals
European cancer centers restructure care in the era of COVID-19
From the Journals
Want to keep cancer patients and providers safe during the pandemic? Here’s how
Prescreening, telemedicine, and limited interventions top the list of best practices for patients, while PPE, telecommuting, and wellness/stress...
From the Journals
CLAM trial regimen shown safe, effective for r/r AML
High response rates and effective bridge to transplant shown.
Feature
Cancer patients report delays in treatment because of COVID-19
Half of survey respondents in active treatment reported changes, delays, or disruptions to care.
From the Journals
Cancer care ‘transformed in space of a month’ because of pandemic
Changes brought about by COVID-19 may endure after the pandemic is over.
From the Journals
Oncologists need to advocate for scarce COVID-19 resources: ASCO
The oncologist treating a patient should not make decisions about resource allocation for that patient, ASCO says.
Feature
ASCO announces its own COVID-19 and cancer registry
ASCO aims to learn how COVID-19 is impacting cancer patients’ treatment and outcomes.
From the Journals
Cancer prevalence among COVID-19 patients may be higher than previously reported
A meta-analysis suggests the cancer prevalence among COVID-19 patients is 2%, not 1% as previously reported.
Feature
Home-based chemo skyrockets at one U.S. center
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
From the Journals
Managing pediatric heme/onc departments during the pandemic
An international group has devised a plan for preventing the spread of infection, treating COVID-19, and adjusting cancer treatments.
From the Journals
One-third of high-risk CLL patients received treatment counter to recommendations
One-third of high-risk chronic lymphocytic leukemia patients received chemoimmunotherapy despite predicted poor outcomes.